APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Andrographolide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Andrographolide Tablets Market Outlook and Growth Opportunities 2026

Report ID 173963460426 December 2025193 pages

Choose your research edition.

Industry ResearchAndrographolide Tablets Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Andrographolide Tablets Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Andrographolide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Andrographolide Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Andrographolide Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Andrographolide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Andrographolide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Andrographolide Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Andrographolide Tablets market include Guangdong Wannianqing Pharmaceutical Co., Ltd., Sinopharm Group Yibin Pharmaceutical Co., Ltd., Hainan Huipson Pharmaceutical Biotechnology Co., Ltd., Henan Furentang Pharmaceutical Co., Ltd., Hubei Keyi Pharmaceutical Co., Ltd., Jiangxi Qingfeng Pharmaceutical Co., Ltd., Quanzhou Zhongqiao Pharmaceutical Co., Ltd., Wuxi Jiyushanwei Pharmaceutical Co., Ltd. and Chongqing Kerui Pharmaceutical (Group) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Andrographolide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Andrographolide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Andrographolide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Andrographolide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Andrographolide Tablets Segment by Company

Guangdong Wannianqing Pharmaceutical Co., Ltd.

Sinopharm Group Yibin Pharmaceutical Co., Ltd.

Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.

Henan Furentang Pharmaceutical Co., Ltd.

Hubei Keyi Pharmaceutical Co., Ltd.

Jiangxi Qingfeng Pharmaceutical Co., Ltd.

Quanzhou Zhongqiao Pharmaceutical Co., Ltd.

Wuxi Jiyushanwei Pharmaceutical Co., Ltd.

Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Andrographolide Tablets Segment by Type

Dispersible Tablets

Conventional Tablets

Andrographolide Tablets Segment by Application

Hospital

Clinic

Other

Andrographolide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Andrographolide Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Andrographolide Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Andrographolide Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Andrographolide Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Andrographolide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Andrographolide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Andrographolide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Andrographolide Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Andrographolide Tablets industry.

Chapter 3: Detailed analysis of Andrographolide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Andrographolide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Andrographolide Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Andrographolide Tablets Industry Trends Table 2. Andrographolide Tablets Industry Drivers Table 3. Andrographolide Tablets Industry Opportunities and Challenges Table 4. Andrographolide Tablets Industry Restraints Table 5. Global Andrographolide Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Andrographolide Tablets Revenue Share by Company (2021-2026) Table 7. Global Andrographolide Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Andrographolide Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Andrographolide Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Andrographolide Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Andrographolide Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Andrographolide Tablets Company, Product Type & Application Table 13. Global Andrographolide Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Andrographolide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Dispersible Tablets Table 18. Significant Companies of Conventional Tablets Table 19. Global Andrographolide Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Andrographolide Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Andrographolide Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Andrographolide Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Andrographolide Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Andrographolide Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Andrographolide Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Andrographolide Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Andrographolide Tablets Sales Value Share by Type (2021-2026) Table 28. Global Andrographolide Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Andrographolide Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Andrographolide Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Andrographolide Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Andrographolide Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Andrographolide Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Andrographolide Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Andrographolide Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Andrographolide Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Andrographolide Tablets Sales Value Share by Application (2021-2026) Table 41. Global Andrographolide Tablets Sales Value Share by Application (2027-2032) Table 42. Global Andrographolide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Andrographolide Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Andrographolide Tablets Sales Market Share by Region (2021-2026) Table 45. Global Andrographolide Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Andrographolide Tablets Sales Market Share by Region (2027-2032) Table 47. Global Andrographolide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Andrographolide Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Andrographolide Tablets Sales Value Share by Region (2021-2026) Table 50. Global Andrographolide Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Andrographolide Tablets Sales Value Share by Region (2027-2032) Table 52. Global Andrographolide Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Andrographolide Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Andrographolide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Andrographolide Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Andrographolide Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Andrographolide Tablets Sales Market Share by Country (2021-2026) Table 58. Global Andrographolide Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Andrographolide Tablets Sales Market Share by Country (2027-2032) Table 60. Global Andrographolide Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Andrographolide Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Andrographolide Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Andrographolide Tablets Sales Value Market Share by Country (2027-2032) Table 64. Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information Table 65. Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview Table 66. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 68. Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Development Table 69. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information Table 70. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview Table 71. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 73. Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Development Table 74. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information Table 75. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview Table 76. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio Table 78. Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Development Table 79. Henan Furentang Pharmaceutical Co., Ltd. Company Information Table 80. Henan Furentang Pharmaceutical Co., Ltd. Business Overview Table 81. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 83. Henan Furentang Pharmaceutical Co., Ltd. Recent Development Table 84. Hubei Keyi Pharmaceutical Co., Ltd. Company Information Table 85. Hubei Keyi Pharmaceutical Co., Ltd. Business Overview Table 86. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 88. Hubei Keyi Pharmaceutical Co., Ltd. Recent Development Table 89. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information Table 90. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview Table 91. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 93. Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Development Table 94. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information Table 95. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview Table 96. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 98. Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Development Table 99. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information Table 100. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview Table 101. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio Table 103. Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Development Table 104. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information Table 105. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview Table 106. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio Table 108. Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Andrographolide Tablets Distributors List Table 112. Andrographolide Tablets Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Andrographolide Tablets Product Image Figure 2. Global Andrographolide Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Andrographolide Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Andrographolide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Andrographolide Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Andrographolide Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Dispersible Tablets Image Figure 10. Conventional Tablets Image Figure 11. Global Andrographolide Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Andrographolide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Andrographolide Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Andrographolide Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Andrographolide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Andrographolide Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Andrographolide Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Andrographolide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Andrographolide Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Andrographolide Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Andrographolide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Andrographolide Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Andrographolide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Andrographolide Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Andrographolide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Andrographolide Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Andrographolide Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Andrographolide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Andrographolide Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Andrographolide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Andrographolide Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Andrographolide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Andrographolide Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Andrographolide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Andrographolide Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Andrographolide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Andrographolide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Andrographolide Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Andrographolide Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Dispersible Tablets
  • Conventional Tablets
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Guangdong Wannianqing Pharmaceutical Co., Ltd.
  • Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  • Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  • Henan Furentang Pharmaceutical Co., Ltd.
  • Hubei Keyi Pharmaceutical Co., Ltd.
  • Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  • Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  • Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  • Chongqing Kerui Pharmaceutical (Group) Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Andrographolide Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Andrographolide Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Andrographolide Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Andrographolide Tablets Market Dynamics
  1. 2.1 Andrographolide Tablets Industry Trends
  2. 2.2 Andrographolide Tablets Industry Drivers
  3. 2.3 Andrographolide Tablets Industry Opportunities and Challenges
  4. 2.4 Andrographolide Tablets Industry Restraints
3 Andrographolide Tablets Market by Company
  1. 3.1 Global Andrographolide Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Andrographolide Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Andrographolide Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Andrographolide Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Andrographolide Tablets Company Ranking (2024-2026)
  6. 3.6 Global Andrographolide Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Andrographolide Tablets Company Product Type and Application
  8. 3.8 Global Andrographolide Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Andrographolide Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Andrographolide Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Andrographolide Tablets Market by Type
  1. 4.1 Andrographolide Tablets Type Introduction
  2. 4.1.1 Dispersible Tablets
  3. 4.1.2 Conventional Tablets
  4. 4.2 Global Andrographolide Tablets Sales Volume by Type
  5. 4.2.1 Global Andrographolide Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Andrographolide Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Andrographolide Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Andrographolide Tablets Sales Value by Type
  9. 4.3.1 Global Andrographolide Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Andrographolide Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Andrographolide Tablets Sales Value Share by Type (2021-2032)
5 Andrographolide Tablets Market by Application
  1. 5.1 Andrographolide Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Andrographolide Tablets Sales Volume by Application
  6. 5.2.1 Global Andrographolide Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Andrographolide Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Andrographolide Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Andrographolide Tablets Sales Value by Application
  10. 5.3.1 Global Andrographolide Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Andrographolide Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Andrographolide Tablets Sales Value Share by Application (2021-2032)
6 Andrographolide Tablets Regional Sales and Value Analysis
  1. 6.1 Global Andrographolide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Andrographolide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Andrographolide Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Andrographolide Tablets Sales by Region (2027-2032)
  5. 6.3 Global Andrographolide Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Andrographolide Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Andrographolide Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Andrographolide Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Andrographolide Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Andrographolide Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Andrographolide Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Andrographolide Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Andrographolide Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Andrographolide Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Andrographolide Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Andrographolide Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Andrographolide Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Andrographolide Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Andrographolide Tablets Sales Value Share by Country, 2025 VS 2032
7 Andrographolide Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Andrographolide Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Andrographolide Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Andrographolide Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Andrographolide Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Andrographolide Tablets Sales by Country (2027-2032)
  6. 7.4 Global Andrographolide Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Andrographolide Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Andrographolide Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Andrographolide Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Andrographolide Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Andrographolide Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Guangdong Wannianqing Pharmaceutical Co., Ltd.
  2. 8.1.1 Guangdong Wannianqing Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Guangdong Wannianqing Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Guangdong Wannianqing Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  6. 8.1.5 Guangdong Wannianqing Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd.
  8. 8.2.1 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  12. 8.2.5 Sinopharm Group Yibin Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd.
  14. 8.3.1 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Company Information
  15. 8.3.2 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Business Overview
  16. 8.3.3 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Andrographolide Tablets Product Portfolio
  18. 8.3.5 Hainan Huipson Pharmaceutical Biotechnology Co., Ltd. Recent Developments
  19. 8.4 Henan Furentang Pharmaceutical Co., Ltd.
  20. 8.4.1 Henan Furentang Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Henan Furentang Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Henan Furentang Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  24. 8.4.5 Henan Furentang Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Hubei Keyi Pharmaceutical Co., Ltd.
  26. 8.5.1 Hubei Keyi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Hubei Keyi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hubei Keyi Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  30. 8.5.5 Hubei Keyi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Jiangxi Qingfeng Pharmaceutical Co., Ltd.
  32. 8.6.1 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  36. 8.6.5 Jiangxi Qingfeng Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Quanzhou Zhongqiao Pharmaceutical Co., Ltd.
  38. 8.7.1 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  42. 8.7.5 Quanzhou Zhongqiao Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Wuxi Jiyushanwei Pharmaceutical Co., Ltd.
  44. 8.8.1 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Andrographolide Tablets Product Portfolio
  48. 8.8.5 Wuxi Jiyushanwei Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Chongqing Kerui Pharmaceutical (Group) Co., Ltd.
  50. 8.9.1 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Company Information
  51. 8.9.2 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Business Overview
  52. 8.9.3 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Andrographolide Tablets Product Portfolio
  54. 8.9.5 Chongqing Kerui Pharmaceutical (Group) Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Andrographolide Tablets Value Chain Analysis
  2. 9.1.1 Andrographolide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Andrographolide Tablets Sales Mode & Process
  6. 9.2 Andrographolide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Andrographolide Tablets Distributors
  9. 9.2.3 Andrographolide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst